Table 2.
Clinical Characteristics and presence of comorbidities
| Clinical characteristics | |
|---|---|
| Family history of diabetes (N, %; Yes) | 555 (48.6) |
| T2DM duration | |
| 0–6 months | 109 (9.6) |
| 6 months to 5 years | 351 (30.8) |
| 6–10 years | 217 (19.0) |
| ≥ 10 years | 464 (40.7) |
| Dyslipidemia (N, %; Yes) | 702 (61.5) |
| Hypertension (N, %; Yes) | 682 (59.8) |
| Treatment modality (N, %) | |
| Diet and exercise | 58 (5.1) |
| Oral antidiabetic agents only | 773 (67.7) |
| Injectable antidiabetic agents only | 131 (11.5) |
| Combination of oral and injectable antidiabetic agents | 180 (15.8) |
| No. of antidiabetic agents used (N, %) | |
| 1 | 719 (66.3) |
| 2 | 279 (25.7) |
| ≥ 3 | 86 (7.9) |
| Hyperthyroid (N, %; Yes) | 21 (1.8) |
| Hypothyroid (N, %; Yes) | 182 (16.0) |
| Coronary artery disease (N, %; Yes) | 247 (21.6) |
| Heart failure (N, %; Yes) | 94 (8.2) |
| Atrial fibrillation (N, %; Yes) | 94 (8.2) |
| Stroke (N, %; Yes) | 53 (4.6) |
| Transient ischemic attach (N, %; Yes) | 50 (4.4) |
| Peripheral arterial disease (N, %; Yes) | 73 (6.4) |
| Peripheral neuropathy (N, %; Yes) | 74 (6.5) |
| Erectile dysfunction (N, %; Yes) | 6 (0.5) |
| Diabetic foot (N, %; Yes) | 25 (2.2) |
| Retinopathy (N, %; Yes) | 57 (5) |
| eGFRa (Mean ± SD; ml/min/1.73m2) | 67.70 ± 17.05 |
CKD chronic kidney disease, eGFR estimated glomerular filtration rate, T2DM type 2 diabetes mellitus
aEstimated using CKD-EPI equation